Class information for:
Level 1: OXYTOCIN RECEPTOR//OXYTOCIN ANTAGONIST//U469

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
7294 1385 34.7 60%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
11 4 NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL 1112395
127 3       OXYTOCIN//BEHAVIORAL SCIENCES//VASOPRESSIN 67291
276 2             OXYTOCIN//VASOPRESSIN//HYPONATREMIA 19172
7294 1                   OXYTOCIN RECEPTOR//OXYTOCIN ANTAGONIST//U469 1385

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 OXYTOCIN RECEPTOR authKW 452782 6% 24% 86
2 OXYTOCIN ANTAGONIST authKW 331945 3% 39% 39
3 U469 address 113664 1% 27% 19
4 V1A VASOPRESSIN RECEPTOR authKW 113375 0% 86% 6
5 OXYTOCIN authKW 112239 11% 3% 150
6 VASOPRESSIN RECEPTOR authKW 111416 2% 17% 30
7 V 2 AGONISTS authKW 110228 0% 100% 5
8 BARUSIBAN authKW 91855 0% 83% 5
9 ATOSIBAN authKW 77235 1% 18% 19
10 ALPHA 2 INDANYLGLYCINE authKW 66137 0% 100% 3

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Endocrinology & Metabolism 2889 18% 0% 255
2 Obstetrics & Gynecology 2110 12% 0% 172
3 Chemistry, Medicinal 1012 9% 0% 120
4 Biochemistry & Molecular Biology 924 25% 0% 342
5 Reproductive Biology 622 4% 0% 62
6 Physiology 566 8% 0% 109
7 Pharmacology & Pharmacy 515 14% 0% 188
8 Biophysics 130 5% 0% 64
9 Cell Biology 105 7% 0% 91
10 Chemistry, Multidisciplinary 65 8% 0% 106

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 U469 113664 1% 27% 19
2 ENDOCRINOL MET CANC 44091 0% 100% 2
3 IMMUNOL NEUROENDOCRINOL 44091 0% 100% 2
4 BIOMETAB 39680 0% 60% 3
5 GENOM DRUG DISCOVERY SCISAKYO KU 33065 0% 50% 3
6 KLIN ABT GEBURTSHILFE GYNAKOL 29393 0% 67% 2
7 OBSTET GYNECOL PERINATAL 29393 0% 67% 2
8 UNITE 469 28341 0% 43% 3
9 ADCP HARLOW 2 22046 0% 100% 1
10 AGR LIFE SCI DAIRY SCI 22046 0% 100% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 INTERNATIONAL JOURNAL OF PEPTIDE AND PROTEIN RESEARCH 14743 3% 2% 41
2 JOURNAL OF PEPTIDE SCIENCE 12500 2% 2% 32
3 JOURNAL OF RECEPTOR RESEARCH 9683 1% 3% 16
4 COLLECTION OF CZECHOSLOVAK CHEMICAL COMMUNICATIONS 9424 4% 1% 56
5 JOURNAL OF MEDICINAL CHEMISTRY 5094 5% 0% 71
6 ENDOCRINOLOGY 3913 5% 0% 67
7 JOURNAL OF PEPTIDE RESEARCH 2890 1% 1% 11
8 BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY 2504 2% 0% 24
9 JOURNAL OF RECEPTOR AND SIGNAL TRANSDUCTION RESEARCH 2062 0% 2% 5
10 BIOLOGY OF REPRODUCTION 1504 2% 0% 29

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 OXYTOCIN RECEPTOR 452782 6% 24% 86 Search OXYTOCIN+RECEPTOR Search OXYTOCIN+RECEPTOR
2 OXYTOCIN ANTAGONIST 331945 3% 39% 39 Search OXYTOCIN+ANTAGONIST Search OXYTOCIN+ANTAGONIST
3 V1A VASOPRESSIN RECEPTOR 113375 0% 86% 6 Search V1A+VASOPRESSIN+RECEPTOR Search V1A+VASOPRESSIN+RECEPTOR
4 OXYTOCIN 112239 11% 3% 150 Search OXYTOCIN Search OXYTOCIN
5 VASOPRESSIN RECEPTOR 111416 2% 17% 30 Search VASOPRESSIN+RECEPTOR Search VASOPRESSIN+RECEPTOR
6 V 2 AGONISTS 110228 0% 100% 5 Search V+2+AGONISTS Search V+2+AGONISTS
7 BARUSIBAN 91855 0% 83% 5 Search BARUSIBAN Search BARUSIBAN
8 ATOSIBAN 77235 1% 18% 19 Search ATOSIBAN Search ATOSIBAN
9 ALPHA 2 INDANYLGLYCINE 66137 0% 100% 3 Search ALPHA+2+INDANYLGLYCINE Search ALPHA+2+INDANYLGLYCINE
10 CONFORMATIONAL CONSTRAINTS 56512 1% 26% 10 Search CONFORMATIONAL+CONSTRAINTS Search CONFORMATIONAL+CONSTRAINTS

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref. in
cl.		 Shr. of ref. in
cl.		 Citations
1 MANNING, M , STOEV, S , CHINI, B , DURROUX, T , MOUILLAC, B , GUILLON, G , (2008) PEPTIDE AND NON-PEPTIDE AGONISTS AND ANTAGONISTS FOR THE VASOPRESSIN AND OXYTOCIN V-1A, V-1B, V-2 AND OT RECEPTORS: RESEARCH TOOLS AND POTENTIAL THERAPEUTIC AGENTS.ADVANCES IN VASOPRESSIN AND OXYTOCIN: FROM GENES TO BEHAVIOUR TO DISEASE. VOL. 170. ISSUE . P. 473 -512 100 46% 113
2 MANNING, M , CHENG, LL , STOEV, S , WO, NC , CHAN, WY , SZETO, HH , DURROUX, T , MOUILLAC, B , BARBERIS, C , (2005) DESIGN OF PEPTIDE OXYTOCIN ANTAGONISTS WITH STRIKINGLY HIGHER AFFINITIES AND SELECTIVITIES FOR THE HUMAN OXYTOCIN RECEPTOR THAN ATOSIBAN.JOURNAL OF PEPTIDE SCIENCE. VOL. 11. ISSUE 10. P. 593 -608 57 85% 16
3 MANNING, M , MISICKA, A , OLMA, A , BANKOWSKI, K , STOEV, S , CHINI, B , DURROUX, T , MOUILLAC, B , CORBANI, M , GUILLON, G , (2012) OXYTOCIN AND VASOPRESSIN AGONISTS AND ANTAGONISTS AS RESEARCH TOOLS AND POTENTIAL THERAPEUTICS.JOURNAL OF NEUROENDOCRINOLOGY. VOL. 24. ISSUE 4. P. 609 -628 73 38% 106
4 MANNING, M , STOEV, S , CHENG, LL , WO, NC , CHAN, WY , (2001) DESIGN OF OXYTOCIN ANTAGONISTS, WHICH ARE MORE SELECTIVE THAN ATOSIBAN.JOURNAL OF PEPTIDE SCIENCE. VOL. 7. ISSUE 9. P. 449 -465 52 85% 30
5 WILLIAMS, PD , PETTIBONE, DJ , (1996) RECENT ADVANCES IN THE DEVELOPMENT OF OXYTOCIN RECEPTOR ANTAGONISTS.CURRENT PHARMACEUTICAL DESIGN. VOL. 2. ISSUE 1. P. 41-58 90 56% 21
6 AKERLUND, M , (2006) TARGETING THE OXYTOCIN RECEPTOR TO RELAX THE MYOMETRIUM.EXPERT OPINION ON THERAPEUTIC TARGETS. VOL. 10. ISSUE 3. P. 423-427 38 88% 20
7 MOUILLAC, B , MANNING, M , DURROUX, T , (2008) FLUORESCENT AGONISTS AND ANTAGONISTS FOR VASOPRESSIN/OXYTOCIN G PROTEIN-COUPLED RECEPTORS: USEFULNESS IN LIGAND SCREENING ASSAYS AND RECEPTOR STUDIES.MINI-REVIEWS IN MEDICINAL CHEMISTRY. VOL. 8. ISSUE 10. P. 996-1005 39 70% 8
8 SCHWARZ, MK , PAGE, P , (2003) PRETERM LABOUR: AN OVERVIEW OF CURRENT AND EMERGING THERAPEUTICS.CURRENT MEDICINAL CHEMISTRY. VOL. 10. ISSUE 15. P. 1441 -1468 87 32% 21
9 MELIN, P , (1993) OXYTOCIN ANTAGONISTS IN PRETERM LABOR AND DELIVERY.BAILLIERES CLINICAL OBSTETRICS AND GYNAECOLOGY. VOL. 7. ISSUE 3. P. 577-600 52 72% 32
10 BORTHWICK, AD , (2010) ORAL OXYTOCIN ANTAGONISTS.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 53. ISSUE 18. P. 6525-6538 29 71% 7

Classes with closest relation at Level 1


Rank Class id link
1 6585 OPC 21268//YM087//VASOPRESSIN RECEPTOR ANTAGONIST
2 28371 PATHOPHYSIOL EXPT NEUROENDOCRINOL//NK 1 NK 2 RECEPTORS//BIOMED PHYSIOL MED BIOPHYS
3 34898 MEDUNITE DIABETOL NUTRAVE HIPPOCRATE 54//POST PHYS EXERCISE//UCL 5474
4 34876 GLIOBLASTOMA CELL STRAIN//UPA PROMOTER//CELL CYCLE PREVALENCE
5 6336 VASOPRESSIN//ARGININE8 VASOPRESSIN//AVP4 8
6 8214 IMPERIAL PARTURIT GRP//MYOMETRIUM//PARTURITION
7 1571 OXYTOCIN//OXYTOCIN RECEPTOR//OXTR
8 8155 ELECTROHYSTEROGRAPHY//MYOMETRIUM//HUMAN MYOMETRIUM
9 20261 SEMINOL CLIN EMBRYOL//NALOXONE BINDING SITE//NURSERY 2
10 11601 NEUROPHYSIN//AVP GENE//NEUROHYPOPHYSEAL DIABETES INSIPIDUS

Go to start page